Provided by Tiger Trade Technology Pte. Ltd.

Biodesix, Inc.

26.63
+2.6010.82%
Post-market: 26.630.00000.00%19:38 EDT
Volume:274.17K
Turnover:7.05M
Market Cap:280.98M
PE:-8.51
High:27.11
Open:24.25
Low:24.11
Close:24.03
52wk High:27.11
52wk Low:5.26
Shares:10.55M
Float Shares:4.98M
Volume Ratio:2.03
T/O Rate:5.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1298
EPS(LYR):-4.6702
ROE:-540.01%
ROA:-14.05%
PB:30.73
PE(LYR):-5.70

Loading ...

Biodesix Earnings Call Signals Strong Growth Momentum

TIPRANKS
·
May 06

Analysts’ Top Healthcare Picks: Biodesix (BDSX), Protagonist Therapeutics (PTGX)

TIPRANKS
·
May 06

Biodesix Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 06

Top Premarket Gainers

MT Newswires Live
·
May 05

Biodesix Q1 EPS $(0.81) Beats $(1.12) Estimate, Sales $25.555M Beat $23.178M Estimate

Benzinga Earnings
·
May 05

BRIEF-Biodesix Q1 Revenue USD 22.3 Million Vs. IBES Estimate USD 23.2 Million

Reuters
·
May 05

Biodesix Announces First Quarter 2026 Results and Highlights

THOMSON REUTERS
·
May 05

Biodesix Q1 EPS USD -0.81

THOMSON REUTERS
·
May 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

Biodesix Inc expected to post a loss of $1.10 a share - Earnings Preview

Reuters
·
May 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 01

Biodesix to report first-quarter results after market close

Reuters
·
Apr 20

William Blair health diagnostics analyst holds analyst/industry conference call

TIPRANKS
·
Apr 11

Biodesix announces annual shareholder meeting

Reuters
·
Apr 10

Biodesix Recognized as a Top Workplace for Third Consecutive Year

GlobeNewswire
·
Apr 10

Biodesix to present AACR data on novel multi-omic MRD monitoring test pipeline

Reuters
·
Apr 06

Biodesix study validates Nodify CDT lung nodule test specificity at 91-97% in 1,100 patients

Reuters
·
Mar 20

Biodesix Earnings Call Signals Growth With Caveats

TIPRANKS
·
Mar 10

Biodesix: Strengthened Balance Sheet, Expanding Sales Force, and Modest Revenue Outperformance Support Buy Rating at Attractive 1x Sales Valuation

TIPRANKS
·
Feb 28

Biodesix: Accelerating Growth, First Positive EBITDA, and Strengthening Risk‑Reward Support Buy Rating

TIPRANKS
·
Feb 27